BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36441069)

  • 1. Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
    Huele EH; Veenboer PW; Wessels FJ; Jonges TN; Meijer RP
    Urol Oncol; 2023 Jan; 41(1):49.e7-49.e12. PubMed ID: 36441069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
    Bryan RT; Liu W; Pirrie SJ; Amir R; Gallagher J; Hughes AI; Jefferson KP; Knight A; Nanton V; Mintz HP; Pope AM; Catto JWF; Patel P; James ND
    Eur Urol; 2021 Jul; 80(1):12-15. PubMed ID: 33653635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer local staging: multiparametric MRI performance following transurethral resection.
    van der Pol CB; Shinagare AB; Tirumani SH; Preston MA; Vangel MG; Silverman SG
    Abdom Radiol (NY); 2018 Sep; 43(9):2412-2423. PubMed ID: 29313114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Panebianco V; De Berardinis E; Barchetti G; Simone G; Leonardo C; Grompone MD; Del Monte M; Carano D; Gallucci M; Catto J; Catalano C
    Eur Radiol; 2017 Sep; 27(9):3759-3766. PubMed ID: 28181054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
    Necchi A; Bandini M; Calareso G; Raggi D; Pederzoli F; Farè E; Colecchia M; Marandino L; Bianchi M; Gallina A; Colombo R; Fossati N; Gandaglia G; Capitanio U; Dehò F; Giannatempo P; Lucianò R; Salonia A; Madison R; Ali SM; Chung JH; Ross JS; Briganti A; Montorsi F; De Cobelli F; Messina A
    Eur Urol; 2020 May; 77(5):636-643. PubMed ID: 31882281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 12. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
    Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
    Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Cipollari S; Carnicelli G; Bicchetti M; Campa R; Pecoraro M; Panebianco V
    Curr Opin Urol; 2020 May; 30(3):377-386. PubMed ID: 32168196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients.
    van Straten CGJI; Bruins MH; Dijkstra S; Cornel EB; Kortleve MDH; de Vocht TF; Kiemeney LALM; van der Heijden AG
    World J Urol; 2023 Jul; 41(7):1829-1835. PubMed ID: 37195314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Zhao SM; Yang TJ; Xu CM; Guo XF; Ma YK; Chen XJ; Li X; He CH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):701-704. PubMed ID: 32773805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.